Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2021 12:14 ET | Source: Draper Esprit VCT plc

Half-year report

Draper Esprit VCT plcLEI:2138003I9Q1QPDSQ9Z97 Half-Yearly Report for the six months ended 30 September 2021 Recent performance summary 30 Sept 2021 31 Mar 2021 30 Sept 2020...
December 13, 2021 12:00 ET | Source: eXp World Holdings, Inc.

eXp Realty Exceeds 70,000 Real Estate Agents Globally

BELLINGHAM, Wash., Dec. 13, 2021 (GLOBE NEWSWIRE) -- eXp Realty®, the fastest-growing real estate brokerage in the world and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today...
December 13, 2021 12:00 ET | Source: OSE Immunotherapeutics

OSE Immunotherapeutics is Pleased to Announce the Continuation of its Phase 2 Trial Testing Anti-IL-7 Receptor Antagonist OSE-127/S95011 in Ulcerative Colitis after the Interim Futility Analysis

NANTES, France, Dec. 13, 2021 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) announces today that the trial’s Independent Data Monitoring Committee (IDMC) completed...
December 13, 2021 11:45 ET | Source: VINCI

Disclosure of transactions in own shares From December 06 to December 10, 2021

Paris, December 13rd, 2021 Disclosure of transactions in own shares From December 06 to December 10, 2021 Within the...
December 13, 2021 11:40 ET | Source: Agfa-Gevaert

Agfa-Gevaert: Aandeleninkoopprogramma – gereglementeerde informatie

Mortsel, België – 13 december 2021 – 17:40 CET In het kader van het aandeleninkoopprogramma dat werd aangekondigd in het persbericht van 10 maart 2021, begon Agfa-Gevaert NV met de aankoop van eigen...
December 13, 2021 11:40 ET | Source: Agfa-Gevaert

Agfa-Gevaert: Share buyback program – regulated information

Mortsel, Belgium – December 13, 2021 – 5:40 p.m. CET Within the framework of the share buyback program which was announced in the press release of March 10, 2021, Agfa-Gevaert NV proceeded with the...
December 13, 2021 11:00 ET | Source: Allogene Therapeutics, Inc.

Allogene Therapeutics Reports Positive Results from Phase 1 UNIVERSAL Study of Single Dose ALLO-715 AlloCAR T™ Cell Therapy in Relapsed/Refractory Multiple Myeloma at the 63rd American Society of Hematology Annual Meeting

ALLO-715 UNIVERSAL Trial is the First Allogeneic anti-BCMA CAR T to Demonstrate Safety and Substantial Efficacy in Multiple Myeloma Updated Data Demonstrate Responses Similar to Approved Autologous...
December 13, 2021 09:46 ET | Source: MT Højgaard Holding A/S

MT Højgaard Holding A/S: Transaktioner i forbindelse med aktietilbagekøbsprogram

MT Højgaard Holding A/S offentliggjorde den 28. september 2021 iværksættelsen af et aktietilbagekøbsprogram på maksimalt op til 40.000 stk. egne aktier til en samlet pris på op til 11.000.000 kr. med...
December 13, 2021 09:46 ET | Source: MT Højgaard Holding A/S

MT Højgaard Holding A/S: Transactions in connection with share buy-back programme

On 28 September 2021, MT Højgaard Holding A/S announced that a share buy-back programme of up to 40,000 treasury shares at an aggregated price of up to DKK 11,000,000 was launched with the purpose to...
December 13, 2021 09:30 ET | Source: Virgin Pulse

Virgin Pulse Named 2021 CCW Excellence Awards Finalist for Best Contact Center Culture and Best in Class Contact Center

PROVIDENCE, R.I., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Virgin Pulse, the leading global provider of tech-enabled solutions focused on improving the health and wellbeing of its members, today...